Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors
by on Friday, August 10th, 2012 | No Comments
Conditions: Glioma; Neuroectodermal Tumors, Primitive; Wilms Tumor; Rhabdomyosarcoma; Sarcoma, Ewing; Osteosarcoma; Retinoblastoma
Interventions: Other: Control; Drug: Metronomic Cyclophosphamide; Drug: Thalomide
Sponsors: Washington University School of Medicine; Washington University School of Medicine
Not yet recruiting – verified August 2012
Visit link: Anti-Angiogenic Therapy Post Transplant (ASCR) for Relapsed and Refractory Pediatric Solid Tumors